Global Veterinary API Manufacturing 麻豆原创 Research Report 2023

Publication ID:

PB504237429

Publication Date:

May 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The increasing number of oral formulations for various veterinary drugs is boosting the demand for veterinary Active Pharmaceutical Ingredients (APIs). These majorly include nonsteroidal anti-inflammatory drugs. Manufacturers are investing in process synthesis, which helps in accelerating the manufacturing process for听active pharmaceutical ingredients.
Highlights
The global Veterinary API Manufacturing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Veterinary API Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Veterinary API Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Veterinary API Manufacturing in In House is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Veterinary API Manufacturing include Alivira Animal Health Ltd., Excel Industries Ltd., Ofichem Group, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Menadiona, Afton Pharma, Jiangsu Lingyun Pharmaceutical Co., Ltd., SUANFARMA and NGL Fine-Chem Ltd., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary API Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary API Manufacturing.
The Veterinary API Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary API Manufacturing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary API Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Menadiona
Afton Pharma
Jiangsu Lingyun Pharmaceutical Co., Ltd.
SUANFARMA
NGL Fine-Chem Ltd.
FIS - Fabbrica Italiana Sintetici S.p.A
Segment by Type
Antiparasitic
Anti-infectives
NSAIDs
Vaccines
Biologics
Others
Segment by Application
In House
Contract Outsourcing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary API Manufacturing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Veterinary API Manufacturing 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antiparasitic
1.2.3 Anti-infectives
1.2.4 NSAIDs
1.2.5 Vaccines
1.2.6 Biologics
1.2.7 Others
1.3 麻豆原创 by Application
1.3.1 Global Veterinary API Manufacturing 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 In House
1.3.3 Contract Outsourcing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary API Manufacturing 麻豆原创 Perspective (2018-2029)
2.2 Veterinary API Manufacturing Growth Trends by Region
2.2.1 Global Veterinary API Manufacturing 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Veterinary API Manufacturing Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Veterinary API Manufacturing Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Veterinary API Manufacturing 麻豆原创 Dynamics
2.3.1 Veterinary API Manufacturing Industry Trends
2.3.2 Veterinary API Manufacturing 麻豆原创 Drivers
2.3.3 Veterinary API Manufacturing 麻豆原创 Challenges
2.3.4 Veterinary API Manufacturing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary API Manufacturing Players by Revenue
3.1.1 Global Top Veterinary API Manufacturing Players by Revenue (2018-2023)
3.1.2 Global Veterinary API Manufacturing Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Veterinary API Manufacturing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary API Manufacturing Revenue
3.4 Global Veterinary API Manufacturing 麻豆原创 Concentration Ratio
3.4.1 Global Veterinary API Manufacturing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary API Manufacturing Revenue in 2022
3.5 Veterinary API Manufacturing Key Players Head office and Area Served
3.6 Key Players Veterinary API Manufacturing Product Solution and Service
3.7 Date of Enter into Veterinary API Manufacturing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary API Manufacturing Breakdown Data by Type
4.1 Global Veterinary API Manufacturing Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Veterinary API Manufacturing Forecasted 麻豆原创 Size by Type (2024-2029)
5 Veterinary API Manufacturing Breakdown Data by Application
5.1 Global Veterinary API Manufacturing Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Veterinary API Manufacturing Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Veterinary API Manufacturing 麻豆原创 Size (2018-2029)
6.2 North America Veterinary API Manufacturing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Veterinary API Manufacturing 麻豆原创 Size by Country (2018-2023)
6.4 North America Veterinary API Manufacturing 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary API Manufacturing 麻豆原创 Size (2018-2029)
7.2 Europe Veterinary API Manufacturing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Veterinary API Manufacturing 麻豆原创 Size by Country (2018-2023)
7.4 Europe Veterinary API Manufacturing 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary API Manufacturing 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Veterinary API Manufacturing 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Veterinary API Manufacturing 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Veterinary API Manufacturing 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary API Manufacturing 麻豆原创 Size (2018-2029)
9.2 Latin America Veterinary API Manufacturing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Veterinary API Manufacturing 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Veterinary API Manufacturing 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary API Manufacturing 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Veterinary API Manufacturing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Veterinary API Manufacturing 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Veterinary API Manufacturing 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alivira Animal Health Ltd.
11.1.1 Alivira Animal Health Ltd. Company Detail
11.1.2 Alivira Animal Health Ltd. Business Overview
11.1.3 Alivira Animal Health Ltd. Veterinary API Manufacturing Introduction
11.1.4 Alivira Animal Health Ltd. Revenue in Veterinary API Manufacturing Business (2018-2023)
11.1.5 Alivira Animal Health Ltd. Recent Development
11.2 Excel Industries Ltd.
11.2.1 Excel Industries Ltd. Company Detail
11.2.2 Excel Industries Ltd. Business Overview
11.2.3 Excel Industries Ltd. Veterinary API Manufacturing Introduction
11.2.4 Excel Industries Ltd. Revenue in Veterinary API Manufacturing Business (2018-2023)
11.2.5 Excel Industries Ltd. Recent Development
11.3 Ofichem Group
11.3.1 Ofichem Group Company Detail
11.3.2 Ofichem Group Business Overview
11.3.3 Ofichem Group Veterinary API Manufacturing Introduction
11.3.4 Ofichem Group Revenue in Veterinary API Manufacturing Business (2018-2023)
11.3.5 Ofichem Group Recent Development
11.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
11.4.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Company Detail
11.4.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Business Overview
11.4.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Introduction
11.4.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Revenue in Veterinary API Manufacturing Business (2018-2023)
11.4.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Development
11.5 Menadiona
11.5.1 Menadiona Company Detail
11.5.2 Menadiona Business Overview
11.5.3 Menadiona Veterinary API Manufacturing Introduction
11.5.4 Menadiona Revenue in Veterinary API Manufacturing Business (2018-2023)
11.5.5 Menadiona Recent Development
11.6 Afton Pharma
11.6.1 Afton Pharma Company Detail
11.6.2 Afton Pharma Business Overview
11.6.3 Afton Pharma Veterinary API Manufacturing Introduction
11.6.4 Afton Pharma Revenue in Veterinary API Manufacturing Business (2018-2023)
11.6.5 Afton Pharma Recent Development
11.7 Jiangsu Lingyun Pharmaceutical Co., Ltd.
11.7.1 Jiangsu Lingyun Pharmaceutical Co., Ltd. Company Detail
11.7.2 Jiangsu Lingyun Pharmaceutical Co., Ltd. Business Overview
11.7.3 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Introduction
11.7.4 Jiangsu Lingyun Pharmaceutical Co., Ltd. Revenue in Veterinary API Manufacturing Business (2018-2023)
11.7.5 Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Development
11.8 SUANFARMA
11.8.1 SUANFARMA Company Detail
11.8.2 SUANFARMA Business Overview
11.8.3 SUANFARMA Veterinary API Manufacturing Introduction
11.8.4 SUANFARMA Revenue in Veterinary API Manufacturing Business (2018-2023)
11.8.5 SUANFARMA Recent Development
11.9 NGL Fine-Chem Ltd.
11.9.1 NGL Fine-Chem Ltd. Company Detail
11.9.2 NGL Fine-Chem Ltd. Business Overview
11.9.3 NGL Fine-Chem Ltd. Veterinary API Manufacturing Introduction
11.9.4 NGL Fine-Chem Ltd. Revenue in Veterinary API Manufacturing Business (2018-2023)
11.9.5 NGL Fine-Chem Ltd. Recent Development
11.10 FIS - Fabbrica Italiana Sintetici S.p.A
11.10.1 FIS - Fabbrica Italiana Sintetici S.p.A Company Detail
11.10.2 FIS - Fabbrica Italiana Sintetici S.p.A Business Overview
11.10.3 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Introduction
11.10.4 FIS - Fabbrica Italiana Sintetici S.p.A Revenue in Veterinary API Manufacturing Business (2018-2023)
11.10.5 FIS - Fabbrica Italiana Sintetici S.p.A Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Menadiona
Afton Pharma
Jiangsu Lingyun Pharmaceutical Co., Ltd.
SUANFARMA
NGL Fine-Chem Ltd.
FIS - Fabbrica Italiana Sintetici S.p.A

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.